This is the text extract for December Tender notification, browse documents here.

---

24 December 2009

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th January 2010. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2007/08 Tender Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 1. Tenders awarded to listed pharmaceuticals where only the current brand is listed – DV Limits and DV Pharmaceuticals will apply from 1 April 2010.

The decisions were as follows:

Chemical Name Cefepime hydrochloride Cefepime hydrochloride

Presentation; Pack size and type Inj 1 g, 15 ml; 1 injection, vial Inj 2 g, 77 ml; 1 injection, vial

Hospital Supply Brand (Supplier) Maxipime (BMS) Maxipime (BMS)

Pack Price $19.55 $39.10

DV Limit 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) (B)

2. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 February 2010 and DV Limits and DV Pharmaceuticals will apply from 1 April 2010.

The decisions were as follows:

Chemical Name Iron sucrose

Presentation; Pack size and type Inj 20 mg per ml, 5 ml; 5 injections, ampoule

Hospital Supply Brand (Supplier) Venofer (Aspen)

Pack Price $100.00

DV Limit 1%

DV Pharmaceuticals Brand Name (Supplier) (B)

A329159 - qA12214

---

2008/09 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where no other brand is listed – Sole Subsidised Supply commences on 1 July 2010.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type

Current Subsidy and (price) $21.10 ($24.10)

New tender subsidy $21.10

Sole supply brand (Supplier) Sandomigran (Novartis)

Pizotifen*

Tab 500 mcg; 100 tablets, blister

*This will become fully funded 4. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing (where applicable) for tender winning brand at the tender subsidy will occur on 1 February 2010, reference pricing of non-tender winning brand will occur on 1 April 2010 and Sole Subsidised Supply commences on 1 July 2010.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Inj 1 mg per ml, 1 ml; 3 injections, ampoule Tab 2.5 mg; 30 tablets, blister Oral liq 5 mg per 5 ml; 100 ml, bottle

Current subsidy $9.21 $146.46 $3.53 ($8.51)

New tender subsidy $6.15 $26.55 $3.10

Sole supply brand (Supplier) ABM Hydroxocobalamin Letara (Douglas) Promethazine Winthrop Elixir (Sanofi-Aventis)

Brands affected by reference pricing and delisting Neo-B12 (Hospira) Femara (Novartis) Phenergan (Sanofi-Aventis) Andriol Testocaps (Schering-Plough) Panteston (Schering-Plough)

Hydroxocobalamin Letrozole Promethazine hydrochloride*

Testosterone undecanoate

Cap 40 mg; 100 capsules, bottle

$60.71 $79.92 Arrow-Testosterone (per 100 (per 60 (Arrow) capsules) capsules)

*This will become fully funded Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 5. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing (where applicable) for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 February 2010; DV Limits and DV pharmaceuticals will apply from 1 April 2010; de-listing of other brands in Section H will occur on 1 April 2010.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Inj 1 mg per ml, 1 ml; 3 injections, ampoule Tab 2.5 mg; 30 tablets, blister

Hospital Supply Brand (Supplier) ABM Hydroxocobalamin Letara (Douglas)

Pack Price $6.15 $26.55

DV Limit 1% 1%

DV Pharmaceuticals Brand Name (Supplier) Neo-B12 (Hospira) Femara (Novartis)

Hydroxocobalamin Letrozole

6. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 February 2010 and DV Limits and DV Pharmaceuticals will apply from 1 April 2010.

A329159 - qA12214

Page 2 of 3

---

The decisions were as follows:

Chemical Name Pizotifen Promethazine hydrochloride Testosterone undecanoate

Presentation; Pack size and type Tab 500 mcg; 100 tablets, blister Oral liq 5 mg per 5 ml; 100 ml, bottle

Hospital Supply Brand (Supplier) Sandomigran (Novartis) Promethazine Winthrop Elixir (Sanofi-Aventis) Arrow-Testosterone (Arrow)

Pack Price $21.10 $3.10

DV Limit 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) Phenergan (Sanofi-Aventis) Andriol Testocaps (Schering-Plough) Panteston (Schering-Plough)

Cap 40 mg; 100 capsules, bottle

$79.92

1%

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A329159 - qA12214

Page 3 of 3